Table 1.
Baseline demographic data and clinical characteristics
| Characteristic | MBSR group (n = 62) | Active controls (n = 52) | Non‐MBSR (n = 52) | Total (n = 166) | ||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | |
| Marital status | ||||||||
| Married/cohabitation | 46 | 74.2 | 35 | 67.3 | 42 | 80.8 | 123 | 74.1 |
| Widowed | 3 | 4.8 | 3 | 5.8 | 4 | 7.7 | 10 | 6.0 |
| Divorced | 6 | 9.7 | 8 | 15.4 | 1 | 1.9 | 15 | 9.0 |
| Single | 5 | 8.1 | 4 | 7.7 | 4 | 7.7 | 13 | 7.8 |
| Partner without l.t.a | 2 | 3.2 | 2 | 3.8 | 1 | 1.9 | 5 | 3.0 |
| Living with | ||||||||
| Partner | 44 | 71.0 | 35 | 67.3 | 41 | 78.8 | 120 | 72.3 |
| Other | 1 | 1.6 | 0 | 0 | 1 | 1.9 | 2 | 1.2 |
| Children | 7 | 11.3 | 2 | 3.8 | 2 | 3.8 | 11 | 6.6 |
| Living alone | 10 | 16.1 | 15 | 28.8 | 8 | 15.4 | 33 | 19.9 |
| Education | ||||||||
| Primary school | 5 | 8.1 | 1 | 1.9 | 1 | 1.9 | 7 | 4.2 |
| Secondary school | 14 | 22.6 | 10 | 19.2 | 11 | 21.2 | 35 | 21.1 |
| Add education–lowerb | 6 | 9.7 | 6 | 11.5 | 10 | 19.2 | 22 | 13.3 |
| Add education– higherc | 7 | 11.3 | 11 | 21.2 | 5 | 9.6 | 23 | 13.9 |
| University | 30 | 48.4 | 24 | 46.2 | 25 | 48.1 | 79 | 47.6 |
| Children | ||||||||
| Yes | 57 | 91.9 | 49 | 94.2 | 45 | 86.5 | 151 | 91.0 |
| No | 5 | 8.1 | 3 | 5.8 | 7 | 13.5 | 15 | 9.0 |
| Employment status | ||||||||
| Working | 38 | 63.3 | 38 | 74.5 | 35 | 68.6 | 111 | 68.5 |
| Unemployed | 1 | 1.7 | 0 | 0 | 0 | 0 | 1 | 0.6 |
| Disability pensioner | 2 | 3.3 | 3 | 5.9 | 1 | 2.0 | 6 | 3.7 |
| Retired | 18 | 30.0 | 10 | 19.6 | 15 | 29.4 | 43 | 26.5 |
| Other | 1 | 1.7 | 0 | 0 | 0 | 0 | 1 | 0.6 |
| Surgery | ||||||||
| Mastectomy | 30 | 48.4 | 26 | 50.0 | 21 | 40.4 | 77 | 46.4 |
| Lumpectomy | 33* | 53.2 | 26 | 50.0 | 30 | 57.7 | 89 | 53.6 |
| Other | 0 | 0 | 0 | 0 | 1 | 1.9 | 1 | 0.6 |
| Tumor size | ||||||||
| <2 cm | 28 | 45.9 | 25 | 49.0 | 32 | 64.0 | 85 | 52.5 |
| 2–5 cm | 25 | 41.0 | 22 | 43.1 | 8 | 16.0 | 55 | 34.0 |
| >5 cm | 8 | 13.1 | 4 | 7.8 | 10 | 20.0 | 22 | 13.6 |
| Type of cancer | ||||||||
| Ductal | 43 | 69.4 | 37 | 71.2 | 40 | 76.9 | 120 | 72.3 |
| Lobular | 13 | 21.0 | 9 | 17.3 | 6 | 11.5 | 28 | 16.9 |
| Other | 6 | 9.7 | 6 | 11.5 | 6 | 11.5 | 18 | 10.8 |
| Receptor | ||||||||
| ER+/PgR+ | 40 | 69.0 | 34 | 72.3 | 39 | 78.0 | 113 | 72.9 |
| ER+/PgR‐ | 8 | 13.8 | 6 | 12.8 | 4 | 8.0 | 17 | 11.6 |
| ER‐/PgR+ | 0 | 0.0 | 0 | 0.0 | 1 | 2.0 | 1 | 0.6 |
| ER‐/PgR‐ | 10 | 17.2 | 7 | 14.9 | 6 | 12.0 | 24 | 14.8 |
| BRE (mean) | 6.6 | 6.5 | 6.6 | |||||
| Treatment postop | ||||||||
| Chemotherapy (CT) | 2 | 3.2 | 3 | 5.8 | 3 | 5.8 | ||
| Radiotherapy (RT) | 3 | 4.8 | 5 | 9.6 | 4 | 7.7 | ||
| Hormonal therapy (HT) | 12 | 19.4 | 14 | 26.9 | 6 | 11.5 | ||
| CT+RT | 11 | 17.8 | 6 | 11.5 | 7 | 13.5 | ||
| CT+ HT | 4 | 6.5 | 0 | 0 | 1 | 1.9 | ||
| RT+ HT | 16 | 25.8 | 13 | 25.0 | 16 | 30.8 | ||
| CT+RT+HT | 13 | 20.9 | 10 | 19.2 | 14 | 26.9 | ||
| No treatment | 1 | 1.6 | 1 | 1.9 | 1 | 1.9 | ||
ER, estrogen receptor; PgR, progesterone receptor.
a
Partner, not living together with.
b
Lower additional education.
c
Higher additional education.